Washington Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Sell
4,030
-175
-4% -$14.1K 0.21% 104
2026
Q1
$364K Sell
4,205
-2,035
-33% -$195K 0.31% 88
2025
Q4
$599K Sell
6,240
-215
-3% -$20.9K 0.49% 63
2025
Q3
$615K Sell
6,455
-500
-7% -$46K 0.44% 57
2025
Q2
$606K Sell
6,955
-1,690
-20% -$143K 0.45% 61
2025
Q1
$777K Hold
8,645
0.63% 38
2024
Q4
$691K Sell
8,645
-50
-0.6% -$4.33K 0.54% 41
2024
Q3
$783K Sell
8,695
-400
-4% -$33.6K 0.6% 43
2024
Q2
$716K Sell
9,095
-180
-2% -$14.8K 0.61% 42
2024
Q1
$808K Sell
9,275
-275
-3% -$23.5K 0.65% 37
2023
Q4
$787K Sell
9,550
-915
-9% -$69.7K 0.67% 39
2023
Q3
$820K Hold
10,465
0.75% 35
2023
Q2
$922K Buy
10,465
+100
+1% +$8.61K 0.78% 33
2023
Q1
$836K Sell
10,365
-145
-1% -$11.8K 0.74% 33
2022
Q4
$817K Sell
10,510
-440
-4% -$35.7K 0.75% 34
2022
Q3
$884K Buy
10,950
+895
+9% +$80.4K 0.89% 32
2022
Q2
$902K Buy
10,055
+1,410
+16% +$143K 0.87% 34
2022
Q1
$959K Buy
8,645
+340
+4% +$35.9K 0.79% 36
2021
Q4
$859K Buy
8,305
+140
+2% +$16.2K 0.7% 38
2021
Q3
$1.02M Sell
8,165
-240
-3% -$31.1K 0.91% 31
2021
Q2
$1.04M Hold
8,405
1.26% 28
2021
Q1
$993K Buy
8,405
+4,145
+97% +$486K 0.92% 27
2020
Q4
$499K Hold
4,260
0.48% 71
2020
Q3
$443K Hold
4,260
0.45% 81
2020
Q2
$391K Sell
4,260
-1,900
-31% -$182K 0.44% 81
2020
Q1
$556K Buy
+6,160
New +$655K 0.7% 38

Other funds holding MDT

Washington Capital Management's MDT Position: Q2 2026 in Review

Washington Capital Management reduced its Medtronic (MDT) stake by 4.2% in Q2 2026, selling an estimated $14.1K and leaving 4,030 shares worth $315K. The position accounts for 0.21% of the portfolio, ranked #104.

Washington Capital Management first reported a position in MDT in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.04M in Q2 2021. 901 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Washington Capital Management held 4,030 shares of Medtronic worth $315K as of Q2 2026.
  • Washington Capital Management sold 175 Medtronic shares in Q2 2026, an estimated $14.1K.
  • Medtronic made up 0.21% of Washington Capital Management's portfolio in Q2 2026, its #104 holding.
  • Washington Capital Management first reported a position in Medtronic in Q1 2020 and has held it in 26 quarters since.
  • Washington Capital Management's Medtronic position peaked at $1.04M in Q2 2021.
  • 901 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Washington Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.